| Literature DB >> 32447046 |
Xin Wang1, Natasha M Resendes2, Lindsey Shanahan3, Lloyd Hutchinson4, Bruce Woda4, Jan Cerny3.
Abstract
Entities:
Keywords: CSF3Rmutations; Chronic neutrophilic leukemia; JAK 1/2 inhibitor; Myeloproliferative neoplasm; Ruxolitinib
Year: 2020 PMID: 32447046 DOI: 10.1016/j.leukres.2020.106384
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156